The product is synthetically developed as compared to the current process of drawing the same from blood plasma and is backed by a granted global patent
This is the eighth Covid-19 vaccine to receive Emergency Use Listing
New bioinformatic workflow advances analysis capabilities for whole-exome assessment and interpretation
The release of this batch will secure the supply for hospitals and cancer centres that are involved in the clinical trials managed by the company
Following the pre-NDA meeting with the U.S. FDA, the companies confirmed the current efficacy and safety databases are expected to be adequate for filing with confirmed pathways for MDD and PPD
The test combines sensitivity with speed and is designed to be used in health care settings to aid with rapid diagnosis of Covid-19
The first patient dosed with VX-880 demonstrated restoration of insulin production and achieved C-peptide of 560 pmol/L in response to Mixed Meal Tolerance Test (MMTT) at Day 90 visit
The WHO chief scientist Soumya Swaminathan tweeted on Oct. 17
Standalone use of Sputnik Light also provides much higher efficacy against severe disease and hospitalizations
This expansion will support the global operations network and help meet global demand for mammalian development services that support Lonza’s manufacturing sites
Subscribe To Our Newsletter & Stay Updated
